surmount-2 tirzepatide type 2 diabetes weight loss results 2023 2024 Efficacy and safety of once‐weekly in Japanese participants with who have obesity or overweight: Subpopulation analysis of the SURMOUNT‐2 trial - Yamauchi - 2025 Relationship of early rapid weight
Description
Under the care of Dr
Mean age showed modest differences (47.3 12.6 vs
doi: 10.1016/j.ntt.2021.106984
I., Nouh, Y
Cardiovascular markers improved consistently across trial populations
